Back to the feed
In brief
On 19.10.2026, a person holding the function "Executive member of the board of directors / senior management" at Kuros Biosciences AG disclosed a purchase worth CHF 282’505 to SIX Exchange Regulation.
This is the largest management purchase disclosed at Kuros Biosciences AG over the previous 12 months (5 purchases in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Kuros Biosciences AG declared a "Purchase" transaction on 19.10.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date19.10.2026
Issuing companyKuros Biosciences AG
ISINCH0325814116
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity59’496
Unit priceCHF 4.75
AmountCHF 282’505
ConditionsAcquisition of shares through exercise of employee
stock options.
ExchangeXSWX
Notification IDT1QAJ00025
Other Kuros Biosciences AG insider transactions
- Sale · Executive member of the board of directors / senior management06.10.2026CHF 552’000
- Purchase · Executive member of the board of directors / senior management22.09.2026CHF 30’600
- Purchase · Executive member of the board of directors / senior management17.09.2026CHF 115’322
- Sale · Executive member of the board of directors / senior management26.05.2026CHF 139’385
- Purchase · Executive member of the board of directors / senior management16.03.2026CHF 65’224
These figures aggregate public disclosures. They are not investment advice.